Want to see SKIN full AI Analyst Report?
Beauty Health (SKIN) Ratios
Beauty Health Ratios
SKIN's free cash flow for Q2 2026 was $1.47M. For the 2026 fiscal year, SKIN's free cash flow was decreased by $-1.21M and operating cash flow was $2.67M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.66 | 7.00 | 6.07 | 10.92 | 13.09 |
| Quick Ratio | 1.40 | 5.99 | 5.28 | 9.39 | 12.63 |
| Cash Ratio | 1.25 | 5.43 | 4.55 | 7.92 | 11.80 |
| Solvency Ratio | 0.04 | 0.00 | -0.08 | 0.08 | -0.39 |
| Operating Cash Flow Ratio | 0.20 | 0.24 | 0.19 | -1.49 | -0.37 |
| Short-Term Operating Cash Flow Coverage | 0.29 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ -129.20M | $ -156.76M | $ -171.47M | $ -52.76M | $ 84.38M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.76 | 0.83 | 0.81 | 0.75 | 0.61 |
| Debt-to-Equity Ratio | 6.20 | 10.97 | 12.67 | 4.50 | 2.47 |
| Debt-to-Capital Ratio | 0.86 | 0.92 | 0.93 | 0.82 | 0.71 |
| Long-Term Debt-to-Capital Ratio | 0.80 | 0.91 | 0.93 | 0.81 | 0.71 |
| Financial Leverage Ratio | 8.18 | 13.24 | 15.64 | 6.00 | 4.03 |
| Debt Service Coverage Ratio | 0.24 | 1.04 | -3.79 | 6.01 | -29.64 |
| Interest Coverage Ratio | -1.08 | -6.51 | -9.59 | -1.93 | -3.39 |
| Debt to Market Cap | 2.10 | 2.80 | 1.80 | 0.55 | 0.30 |
| Interest Debt Per Share | 62.99 | 4.67 | 5.82 | 5.19 | 7.42 |
| Net Debt to EBITDA | 3.77 | 19.16 | -4.28 | 2.25 | 0.44 |
| Profitability Margins | |||||
| Gross Profit Margin | 65.28% | 54.53% | 38.97% | 68.00% | 68.65% |
| EBIT Margin | 4.45% | -5.72% | -22.17% | 16.05% | -141.82% |
| EBITDA Margin | 12.88% | 3.09% | -13.46% | 22.30% | -134.93% |
| Operating Profit Margin | -6.92% | -20.27% | -32.89% | -7.06% | -15.35% |
| Pretax Profit Margin | -1.97% | -8.84% | -25.60% | 12.39% | -146.35% |
| Net Profit Margin | -3.16% | -8.70% | -25.16% | 12.09% | -145.63% |
| Continuous Operations Profit Margin | -3.16% | -8.70% | -25.16% | 12.09% | -145.63% |
| Net Income Per EBT | 160.31% | 98.47% | 98.26% | 97.54% | 99.51% |
| EBT Per EBIT | 28.54% | 43.60% | 77.83% | -175.45% | 953.31% |
| Return on Assets (ROA) | -1.90% | -4.24% | -10.78% | 4.41% | -31.08% |
| Return on Equity (ROE) | -15.58% | -56.17% | -168.57% | 26.47% | -125.30% |
| Return on Capital Employed (ROCE) | -6.64% | -10.97% | -16.08% | -2.77% | -3.50% |
| Return on Invested Capital (ROIC) | -4.70% | -10.72% | -15.71% | -2.69% | -3.47% |
| Return on Tangible Assets | -2.82% | -5.65% | -13.51% | 5.31% | -36.45% |
| Earnings Yield | -5.42% | -14.78% | -24.45% | 3.29% | -15.35% |
| Efficiency Ratios | |||||
| Receivables Turnover | 12.83 | 11.75 | 7.23 | 4.70 | 5.06 |
| Payables Turnover | 6.69 | 6.93 | 5.43 | 4.11 | 2.81 |
| Inventory Turnover | 2.18 | 2.20 | 2.66 | 1.07 | 2.31 |
| Fixed Asset Turnover | 21.33 | 17.08 | 15.11 | 10.82 | 8.34 |
| Asset Turnover | 0.60 | 0.49 | 0.43 | 0.36 | 0.21 |
| Working Capital Turnover Ratio | 1.13 | 0.67 | 0.61 | 0.45 | 0.55 |
| Cash Conversion Cycle | 141.69 | 144.35 | 120.43 | 330.66 | 99.97 |
| Days of Sales Outstanding | 28.44 | 31.08 | 50.47 | 77.59 | 72.17 |
| Days of Inventory Outstanding | 167.77 | 165.96 | 137.24 | 341.81 | 157.82 |
| Days of Payables Outstanding | 54.53 | 52.69 | 67.28 | 88.73 | 130.02 |
| Operating Cycle | 196.21 | 197.04 | 187.71 | 419.39 | 229.99 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 5.93 | 0.13 | 0.17 | -0.72 | -0.28 |
| Free Cash Flow Per Share | 5.12 | 0.08 | 0.07 | -0.84 | -0.43 |
| Dividend Paid and CapEx Coverage Ratio | 7.26 | 2.37 | 1.67 | -6.13 | -1.82 |
| Capital Expenditure Coverage Ratio | 7.26 | 2.37 | 1.67 | -6.13 | -1.82 |
| Operating Cash Flow Coverage Ratio | 0.10 | 0.03 | 0.03 | -0.14 | -0.04 |
| Operating Cash Flow to Sales Ratio | 0.12 | 0.05 | 0.05 | -0.29 | -0.11 |
| Free Cash Flow Yield | 18.40% | 4.74% | 2.12% | -9.23% | -1.78% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -17.38 | -6.91 | -4.09 | 30.36 | -6.51 |
| Price-to-Sales (P/S) Ratio | 0.58 | 0.59 | 1.03 | 3.67 | 9.49 |
| Price-to-Book (P/B) Ratio | 2.88 | 3.80 | 6.90 | 8.04 | 8.16 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 5.43 | 21.08 | 47.07 | -10.83 | -56.10 |
| Price-to-Operating Cash Flow Ratio | 4.69 | 12.20 | 18.83 | -12.60 | -86.99 |
| Price-to-Earnings Growth (PEG) Ratio | 0.27 | 0.10 | 0.01 | -0.28 | -0.02 |
| Enterprise Value Multiple | 8.30 | 38.20 | -11.93 | 18.70 | -6.59 |
| Enterprise Value | 321.67M | 394.98M | 638.79M | 1.53B | 2.31B |
| EV to EBITDA | 8.30 | 38.20 | -11.93 | 18.70 | -6.59 |
| EV to Sales | 1.07 | 1.18 | 1.61 | 4.17 | 8.89 |
| EV to Free Cash Flow | 9.95 | 42.29 | 73.42 | -12.31 | -52.56 |
| EV to Operating Cash Flow | 8.58 | 24.48 | 29.37 | -14.32 | -81.51 |
| Tangible Book Value Per Share | -16.03 | -0.96 | -0.98 | -0.03 | 1.20 |
| Shareholders’ Equity Per Share | 9.67 | 0.42 | 0.45 | 1.13 | 2.96 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.60 | 0.02 | 0.02 | 0.02 | 0.00 |
| Revenue Per Share | 47.60 | 2.70 | 3.02 | 2.48 | 2.55 |
| Net Income Per Share | -1.51 | -0.23 | -0.76 | 0.30 | -3.71 |
| Tax Burden | 1.60 | 0.98 | 0.98 | 0.98 | 1.00 |
| Interest Burden | -0.44 | 1.54 | 1.15 | 0.77 | 1.03 |
| Research & Development to Revenue | 0.02 | 0.02 | 0.03 | 0.02 | 0.03 |
| SG&A to Revenue | 0.70 | 0.73 | 0.33 | 0.29 | 0.38 |
| Stock-Based Compensation to Revenue | 0.05 | 0.08 | 0.06 | 0.08 | 0.05 |
| Income Quality | -3.94 | -0.55 | -0.22 | -2.40 | 0.08 |
Currency in USD
